Semi-standardised homeopathic treatment of premenstrual syndrome with a limited number of medicines: Feasibility study

Homeopathy

Volumn 99, Issue 3, 2010, Pages 192-204

  Klein Laansma, C T ^a   Jansen, J C H ^a   van Tilborgh, A J W ^a   Van der Windt, D A W M ^b,c   Mathie, R T ^d   Rutten, A L B ^a  

^a Dutch Association of Homeopathic Physicians (Artsenvereniging voor homeopathic VHAN)   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KEELE UNIVERSITY   (United Kingdom)

^d BRITISH HOMEOPATHIC ASSOCIATION   (United Kingdom)

Author keywords

Diagnostic algorithm; Expert panel; Feasibility study; Homeopathy; Predictive value; Premenstrual symptoms; Premenstrual syndrome; Questionnaire

Indexed keywords

CALCAREA CARBONICA; HOMEOPATHIC AGENT; LAC CANINUM; LACHESIS MUTUS; MAGNESIUM; MAGNESIUM CARBONICUM; MAGNESIUM PHOSPHORICUM; NATRIUM MURIATICUM; PHOSPHORUS; SODIUM; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; CIMICIFUGA RACEMOSA; CLINICAL PRACTICE; CUTTLEFISH; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HOMEOPATHY; HUMAN; INFORMATION PROCESSING; LILIUM TIGRINUM; LILY; MENSTRUAL CYCLE; PATIENT COMPLIANCE; PREMENSTRUAL SYNDROME; PULSATILLA; PULSATILLA PRATENSIS; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; ALGORITHMS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HOMEOPATHY; HUMANS; MATERIA MEDICA; MIDDLE AGED; PATIENT SELECTION; PHYTOTHERAPY; PLANT EXTRACTS; PREMENSTRUAL SYNDROME; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955244552     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2010.05.007     Document Type: Article

References (41)

1. Schagen van Leeuwen J. NVOG-richtlijn No 19, January 1999, het premenstrueel syndroom, p 1.
2. Diagnostic and Statistic Manual of Mental Disorders 1994, (DSM-IV), American Psychiatric Press, Washington. 4th edn.
3. Halbreich U., Backstrom T., Eriksson E., et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol March 2007, 23(3):123-130.
4. Dickerson L.M., Pharm D., Mazyck P.J., Pharm D., Hunter M.H. Premenstrual syndrome. Am Fam Physician 2003, 67(8):1743-1752.
5. Wyatt K.M., Dimmock P.W., Frischer M., Jones P.W., O'Brien S.P.M. Prescribing patterns in premenstrual syndrome. BMC Womens Health 2002, 2:4.
6. Kolthoff F., Labots-Vogelesang M., Lagro-Jansen T. Het premenstrueel syndroom, prevalentie en kenmerken van patiënten in een huisartsenpraktijk. Huisarts Wetenschap 2005, 48:109-112.
7. Hylan T.R., Sundell K., Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior; experience from the United States, United Kingdom and France. J Womens Health Gend Based Med 1999, 8(8):1043-1052.
8. Dean B.B., Borestein J.E. A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. J Occup Environ Med 2004, 46(7):649-656.
9. Wyatt K., Dimmock P., Jones P., Obhrai M., O'Brien S. Efficacy of progesterone and progestagens in management of premenstrual syndrome: systematic review. Br Med J 2001, 323:776-780.
10. Brown J., O'Brien P.M.S., Marjoribanks J., Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Syst Rev 2002, (3):CD001396. [update 2008]. 10.1002/14651858.CD001396.
11. Sundström-Poromaa I., Bixo M., Björn I., Nordh O. Compliance to antidepressant drug therapy for treatment of premenstrual syndrome. J Psychosom Obstet Gynaecol 2000, 21(4):205-211.
12. Lepaisant C. Clinical trials in homeopathy: treatment of mastodynia due to premenstrual syndrome. Rev Fr Gynecol Obstet 1995, 90(2):94-97.
13. Yakir M., Kreitler S., Brzezinski A., Vithoulkas G., Oberbaum M., Bentwich Z. Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study. Br Hom J 2001, 90(3):148-153.
14. Chapman E.H., Angelica J., Spitalny G., Strauss M. Results of a study of the homeopathic treatment of PMS. J Am Inst Homeopath 1994, 87(1):14-21.
15. Komar T., Peck K.S., Torline J.R., Deroukakis M. A qualitative study to determine the efficacy of the homeopathic simillimum in the treatment of premenstrual syndrome. Am J Homeopath Med 2006, 99(3):196-204.
16. Fäustle R. Behandlung des prämenstruellen Syndroms mit einem homoöpathischen Kombinationspräparat. Biol Med 1992, 6:423-426.
17. Hasson F., Keeney S., McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000, 32:1008-1015.
18. Akins R.B., Tolson H., Cole B.R. Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol 2005, 5:37.
19. Kitzinger J. Qualitative research. Introducing focus groups. Br Med J 1995, 311:299-302.
20. Mathie R.T., Robinson T.W. Outcomes from homeopathic prescribing in medical practice: a prospective, research-targeted, pilot study. Homp 2006, 95:199-205.
21. Stolper C.F., Lugten R.F., Rutten L. Materia medica validation: Phosphoricum acidum and Phosphorus. Similia Similibus Curentur 2000, 30(2):34-35.
22. Stolper C.F., Barthels R.J., Lugten R.F., Rutten A.L.B. Materia medica validation: Lachesis and Tarentula. Similia Similibus Curentur 2000, 30(4):18-20.
23. Stolper C.F., Barthels R.J., Lugten R.F., Rutten A.L.B. Materia medica validation: Pulsatilla. Similia Similibus Curentur 2005, 35(1):19-20.
24. Stolper C.F., Barthels R.J., Lugten R.F., Rutten A.L.B. Materia medica validation: Natrium muriaticum. Similia Similibus Curentur 2007, 37(2):12-14.
25. Assilem M. Folliculinum: mist or miasm?. Homp 1991, 11(1):5-11.
26. Cooper D.J. Folliculinum. Br Hom J 1990, 79:100-103.
27. Martinez B. Folliculinum: efficacy in premenstrual syndrome. Br Hom J 1990, 79:104-105.
28. Antai A.B., Udezi A.W., Ekanem E.E., Okon U.J., Umoiyoho A.U. Premenstrual syndrome: prevalence in students of the University of Calaber, Nigeria. Afr J Biomed Res 2004, 7:45-50.
29. van der Ploeg H.M., Lodder E.B. Longitudinal measurement in the diagnosis of the premenstrual syndrome. J Psychosom Res 1993, 37(1):33-38.
30. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2006 on the Community Code relating to the Medicinal Products for Human Use. Official Journal L-311, 28/11/2004 Chap 2, Article 14, pp 67-128.
31. Reilly D., Duncan S., Bikker A., Heirs M. The development of the GHHOS The IDCCIM Action Research & The PC-HICOM Project. Online document at:, Interim Report. http://www.adhom.com.
32. Reilly D., Mercer S.W., Bikker A.P., Harrison T. Outcome related to impact on daily living: preliminary validation of the ORIDL instrument. BMC Health Serv Res 2007, 7:139.
33. Borenstein J.E., Dean B.B., Leifke E., Korner P., Yonkers K.A. Differences in symptom scores and health outcomes in premenstrual syndrome. J Womens Health 2007, 16(8):1139-1144.
34. Vickers A.J., van Haselen R.A., Pang L., Berkovitz S. Inter-rater reliability of symptom repertorisation: a pragmatic empirical study. Br Hom J 2000, 89:188-190.
35. Bell I. Evidence based homeopathy: empirical questions and methodological considerations for homeopathic clinical research. Am J Homeopath Med 2003, 96(1):17-31.
36. Rutten A.L.B., Stolper C.F., Lugten R.F., Barthels R.J. Statistical analysis of six repertory-rubrics after prospective assessment applying Bayes' theorem. Homp 2009, 98:26-34.
37. Brigo B., Serpelloni G. Homeopathic treatment of migraine: a randomised double-blind study of sixty cases. Berlin J Res Homeopath 1991, 2:98-106.
38. Frei H., von Ammon K., Thurneysen A. Treatment of hyperactive children: increased efficiency through modifications of homeopathic diagnostic procedure. Homp 2006, 95:163-170.
39. Frei H., Everts R., von Ammon K., et al. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Homp 2007, 96:35-41.
40. Logue C., Moos R.H. Perimenstrual symptoms: prevalence and risk factors. Psychosom Med 1986, 48:388-414.
41. Mishell D. Premenstrual disorders: epidemiology and disease burden. Am J Manag Care 2005, 11(16):S473-S479. Rates adapted from Sternfeld B. Obstet Gynaecol 2002; 99:1014-1024.